PURPOSE: To develop concise, patient-focussed, up to date, evidence-based, expert
consensus recommendations for the management of hip and knee osteoarthritis (OA), which are …

… Altman has received consultant fees, speaking fees, and/or honoraria (less than $10,000
each) from Ferring, Rotta, Endo, Novartis, Lilly, and Smith & Nephew. Dr. Towheed has …

… Altman has received consulting fees, speaking fees, and/or honoraria from Flexion,
GlaxoSmithKline, Novartis, Olatec, Pfizer, Sorrento Therapeutics, and Teva Pharmaceutical …

OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 January …

A comment on this article appears in" Fluoroscopically directed steroid instillation in the
treatment of hip osteoarthritis: safety and efficacy in 510 cases." Arthritis Rheum. 2001 Oct; 44 (10…

PURPOSE: As a prelude to developing updated, evidence-based, international consensus
recommendations for the management of hip and knee osteoarthritis (OA), the Osteoarthritis …

INTERVENTIONS-MANUAL THERAPY: Clinicians should consider utilizing thrust manipulative
procedures to reduce pain and disability in patients with mobility deficits and acute low …

OBJECTIVE: Develop a radiographic atlas of osteoarthritis (OA) to be used as a template and
guide for grading radiographs of osteoarthritic lesions of the hand, hip and knee. METHOD…

Objective To evaluate the efficacy and safety of a standardized and highly concentrated extract
of 2 ginger species, Zingiber officinale and Alpinia galanga (EV.EXT 77), in patients with …

Background: The OARSI Standing Committee for Clinical Trials Response Criteria Initiative
had developed two sets of responder criteria to present the results of changes after treatment …